Financial Gravity Asset Management, Inc. Fibrogen Inc Transaction History

Financial Gravity Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 28, 2020	SELL	$34.58 - $48.06 $34 - $48	-1 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$35.13 - $55.53 $35 - $55	1 New	1 $0
Q1 2019 Apr 19, 2019	SELL	$42.83 - $59.91 $214 - $299	-5 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$56.3 - $67.25 $112 - $134	2 Added 66.67%	5 $0
Q2 2018 Aug 14, 2018	BUY	$44.9 - $64.95 $134 - $194	3 New	3 $0

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.